We demonstrate here the robustness of our diazonium-ani-line-protein derivatives Biochip. We performed 112 ovalbumin injections each followed by injection of regeneration buffer (Glycine/HCl). After more than one hundred regenerations, the biochip remains active as indicated in figure 3..